title: [Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: A retrospective analysis of the rivaroxaban once daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation (ROCKET AF)].
authors.affiliation: Atención Primaria, Centro de Salud Casas Ibáñez, Albacete, España; Facultad de Medicina, Universidad Católica San Antonio de Murcia (UCAM), Murcia, España; Grupo HTA SEMERGEN. Electronic address: jadivison@telefonica.net.
authors.forename: J A
authors.initials: JA
authors.lastname: Divisón Garrote
authors.affiliation: Servicio de Cardiología, Hospital La Paz, Madrid, España; Grupo HTA SEMERGEN.
authors.forename: C
authors.initials: C
authors.lastname: Escobar Cervantes
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy*; D004077:Digoxin / Q000627:therapeutic use*; D004617:Embolism / Q000209:etiology / Q000517:prevention & control; D065427:Factor Xa Inhibitors / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D012189:Retrospective Studies; D000069552:Rivaroxaban / Q000008:administration & dosage* / Q000627:therapeutic use; D020521:Stroke / Q000209:etiology / Q000517:prevention & control; D014812:Vitamin K / Q000037:antagonists & inhibitors
chemical_list: D000889:Anti-Arrhythmia Agents; D000925:Anticoagulants; D065427:Factor Xa Inhibitors; D014812:Vitamin K; D004077:Digoxin; D000069552:Rivaroxaban